Literature DB >> 18226612

The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia.

Kenneth J Moise1.   

Abstract

The use of Doppler ultrasound evaluation to measure the peak systolic velocity of the fetal middle cerebral artery (MCA) has been a major breakthrough in the noninvasive detection of fetal anemia. An elevated peak MCA velocity of >1.5 multiples of the median is useful in the timing of the initial intrauterine transfusion (IUT) in the red cell-alloimmunized pregnancies. Data reported to date suggest that a threshold of 1.32 multiples of the median can be used to time the second IUT; the MCA Doppler evaluation does not appear sensitive for the timing of subsequent IUTs in these pregnancies. The peak MCA velocity has also proved useful in the detection of other anemic states that include Kell alloimmunization, fetal parvovirus infection, fetomaternal hemorrhage, alphathalassemia, and after-laser therapy for twin-twin transfusion.

Entities:  

Mesh:

Year:  2008        PMID: 18226612     DOI: 10.1016/j.ajog.2007.10.788

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  Clinical manifestations of α-thalassemia.

Authors:  Elliott P Vichinsky
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

2.  The effect of fetal heart rate on the peak systolic velocity of the fetal middle cerebral artery.

Authors:  Anthony E Swartz; Michael S Ruma; Eunhee Kim; Amy H Herring; M Kathryn Menard; Kenneth J Moise
Journal:  Obstet Gynecol       Date:  2009-06       Impact factor: 7.661

3.  Gestational Diabetes Mellitus and Early Hemodynamic Changes in Fetus.

Authors:  Erdem Fatihoglu; Sonay Aydin; Erdal Karavas; Mecit Kantarci
Journal:  J Med Ultrasound       Date:  2021-05-24

4.  Long-term persistent fetomaternal hemorrhage.

Authors:  Takeshi Umazume; Mamoru Morikawa; Takahiro Yamada; Kazutoshi Cho; Nobuo Masauzi; Hisanori Minakami
Journal:  Clin Case Rep       Date:  2015-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.